Sponsor or institution
Clinical trials and research at Kyverna Therapeutics
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Kyverna Therapeutics that are recruiting, at sites in 6 countries (most in United States (2), Australia (1), Brazil (1)). By phase: Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 6Countries
All recruiting trials (2)
-
Long-term follow-up after KYV-101 (CAR T) treatment
This follow-up will test how long KYV-101 CAR T cells persist and record any delayed side effects in people who previously received KYV-101 for autoimmune diseases like lupus nephritis, myasthenia gravis, stiff person syndrome, rheumatoid arthritis, or multiple sclerosis.
-
Anti-CD19 CAR T-Cell Therapy for Refractory Myasthenia Gravis
This study is testing a new CAR T-cell therapy to see if it can help adults with tough-to-treat myasthenia gravis feel better.
Quick answers
How many clinical trials run by Kyverna Therapeutics are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (2 trials), Australia (1 trial), Brazil (1 trial), Germany (1 trial), Saudi Arabia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.